Reports for SANIS HEALTH INC
Company Name
SANIS HEALTH INC
Totals |
||
Shortage reports |
646 |
|
| Actual shortage: | 67 (10%) | |
| Anticipated shortage: | 1 (0%) | |
| Avoided shortage: | 16 (2%) | |
| Resolved: | 562 (87%) | |
Discontinuation Reports |
72 |
|
| To be discontinued: | 7 (10%) | |
| Discontinued: | 54 (75%) | |
| Reversed: | 11 (15%) | |
Late reports |
52 (7%) |
|
Overdue reports |
17 (23%) |
|
Shortage reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| ROSUVASTATIN | 10MG | TABLET | Resolved | 2023-06-22 | 2023-09-06 | 196102 |
| ROSUVASTATIN | 40MG | TABLET | Resolved | 2025-10-06 | 2025-12-09 | 268699 |
| SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Avoided shortage | 2020-05-11 | 2020-07-08 | 114733 |
| SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Resolved | 2025-02-10 | 2025-06-24 | 250070 |
| SALBUTAMOL HFA | 100MCG | METERED-DOSE AEROSOL | Anticipated shortage | 2025-09-08 | 2025-09-08 | 266772 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2021-03-17 | 2021-07-18 | 135808 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2021-03-17 | 2021-07-18 | 135812 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2021-03-17 | 2021-08-04 | 135815 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2023-07-17 | 2023-09-06 | 198792 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2023-07-18 | 2023-10-17 | 198926 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211071 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2023-11-22 | 2023-12-01 | 211074 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216254 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-01-17 | 2024-02-12 | 216259 |
| SERTRALINE | 25MG | CAPSULE | Resolved | 2024-01-17 | 2024-05-17 | 216264 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-01-17 | 2024-06-06 | 216267 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-01-30 | 2024-05-17 | 217783 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-02-26 | 2024-05-02 | 220633 |
| SERTRALINE | 50MG | CAPSULE | Resolved | 2024-02-26 | 2024-06-19 | 220643 |
| SERTRALINE | 100MG | CAPSULE | Resolved | 2024-03-25 | 2024-04-23 | 223214 |
Discontinuation reports
| Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
|---|---|---|---|---|---|---|
| DILTIAZEM CD | 180MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2416 |
| DILTIAZEM CD | 240MG | CAPSULE (CONTROLLED-DELIVERY) | Reversed | 2017-03-14 | 2017-07-31 | 2421 |
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107342 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107353 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107357 | ||
| DILTIAZEM CD | Discontinued | 2020-02-27 | 2020-02-27 | 107364 | ||
| DIVALPROEX | 125MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2389 |
| DIVALPROEX | 250MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2396 |
| DIVALPROEX | 500MG | TABLET (ENTERIC-COATED) | Reversed | 2017-03-14 | 2017-07-31 | 2402 |
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107369 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107372 | ||
| DIVALPROEX | Discontinued | 2020-02-27 | 2020-02-27 | 107375 | ||
| DULOXETINE | 60MG | CAPSULE (DELAYED RELEASE) | To be discontinued | 2024-02-15 | 2024-02-15 | 219591 |
| DULOXETINE | 30MG | CAPSULE (DELAYED RELEASE) | Reversed | 2024-02-15 | 2024-04-23 | 219618 |
| ETIDROCAL | 400MG 500MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4959 |
| FENOFIBRATE MICRO | 200MG | CAPSULE | Discontinued | 2017-08-02 | 2017-08-02 | 17972 |
| FENOFIBRATE-S | 100MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4891 |
| FENOFIBRATE-S | 160MG | TABLET | Discontinued | 2017-03-31 | 2017-03-31 | 4894 |
| HYDROXYUREA | 500MG | CAPSULE | Discontinued | 2017-04-03 | 2017-04-03 | 5084 |
| INDAPAMIDE | 2.5MG | TABLET | Discontinued | 2017-03-14 | 2017-03-14 | 2450 |